Highlights
NASDAQ: EYPT       Eyepoint Pharmaceuticals Inc
Last Price Today's Change   Day's Range   Trading Volume
0.41   -0.049 (10.68%)  0.40 - 0.461  1,710,000

Overview

 
Avg Volume (4 weeks):1,910,109
4 Weeks Range:0.40 - 0.64
4 Weeks Price Volatility (%):
4.17%
52 Weeks Range:0.40 - 2.53
52 Weeks Price Volatility (%):
0.47%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

EyePoint Pharmaceuticals Inc, formerly pSivida Corp is a US-based specialty pharmaceutical company which is engaged in developing sustained-release drug delivery products and technologies to treat serious, debilitating diseases of the eye that can lead to blindness. The company has developed three sustained-release products for the treatment of back-of-the-eye diseases. The lead product candidate is Durasert which is designed to treat chronic non-infectious uveitis affecting the posterior segment of the eye for three years from a single injection. The company's development program is focused primarily on utilizing two core technology platforms to deliver drugs and biologics to treat chronic diseases.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

2228  6332  529  166 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 SNAP 41.27-1.90 
 DSS 6.82+2.78 
 AAPL 115.05+0.01 
 GE 7.38-0.25 
 SPY 339.39-6.39 
 AAL 11.80-0.80 
 SQQQ 22.58+0.98 
 GRIL 2.04+0.51 
 OAS 0.155-0.014 
 NIO 26.01-1.15